1. Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol. (August 2020) Authors: Avallone, Antonio; Piccirillo, Maria Carmela; Di Gennaro, Elena; Romano, Carmela; Calabrese, Filomena; Roca, Maria Serena; Tatangelo, Fabiana; Granata, Vincenza; Cassata, Antonio; Cavalcanti, Ernesta; Maurea, Nicola; Maiolino, Piera; Silvestro, Lucrezia; De Stefano, Alfonso; Giuliani, Francesco; ... Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗